Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. May 15, 2019; 11(5): 377-392
Published online May 15, 2019. doi: 10.4251/wjgo.v11.i5.377
Published online May 15, 2019. doi: 10.4251/wjgo.v11.i5.377
Figure 4 Effect of QFGs on the mitochondria-dependent and death receptor pathways in HCT-116 and HCT-8 cells.
A: The cells were treated with or without QFGs (2 mg/mL) in combination with different caspase inhibitors (Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK) for 24 h, and then cell viability was measured by MTT assay for each combination. aP < 0.05, bP < 0.01 vs the control group, cP < 0.01 vs the inhibitor group; B: Cells were treated with or without QFGs (2 mg/mL) in combination with different caspase inhibitors (Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK) for 24 h, and then apoptosis in the HCT-116 and HCT-8 cells was detected by Hoechst 33258 staining and visualized under a fluorescent microscope (200 ×). QFGs: Qingjie Fuzheng granules; Z-DEVD-FMK: Inhibitor of caspase-3; Z-IETD-FMK: Inhibitor of caspase-8; Z-LEHD-FMK: Inhibitor of caspase-9.
- Citation: Yang H, Liu JX, Shang HX, Lin S, Zhao JY, Lin JM. Qingjie Fuzheng granules inhibit colorectal cancer cell growth by the PI3K/AKT and ERK pathways. World J Gastrointest Oncol 2019; 11(5): 377-392
- URL: https://www.wjgnet.com/1948-5204/full/v11/i5/377.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i5.377